CRNX · Crinetics Pharmaceuticals, Inc.

$83.90 +0.03 (+0.04%) At close · Jul 21

Market Cap

$8.85B

105.44M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$718,500	—	$3,280,540	$7,160,564	$462,355	$7,000	$11,628,959
Tobin Schilke	CFO	$452,250	—	$1,755,000	$1,670,920	$206,056	$273,667	$4,357,893
Dana Pizzuti	Chief Medical and Development Officer	$573,333	—	$1,584,980	$1,487,018	$258,000	$7,000	$3,910,331
Stephen F. Betz	Chief Scientific Officer	$520,000	—	$1,584,980	$1,487,018	$228,150	$7,000	$3,827,148
Jeff Knight	COO	$511,667	—	$1,584,980	$1,487,018	$236,006	$7,000	$3,826,671
Marc J. Wilson	CFO	$119,788	—	$514,620	$2,556,937	—	$64,047	$3,255,392

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$653,833	—	$2,828,150	$6,640,800	$407,796	$3,000	$10,533,579
Marc J. Wilson	CFO	$468,900	—	$1,109,505	$2,642,485	$211,005	$3,000	$4,434,895
Dana Pizzuti	Chief Medical and Development Officer	$550,833	—	$1,000,730	$2,407,290	$247,875	$3,000	$4,209,728
Stephen F. Betz	Chief Scientific Officer	$491,667	—	$1,000,730	$2,407,290	$221,250	$3,000	$4,123,937
Jeff Knight	COO	$490,000	—	$1,000,730	$2,407,290	$221,970	$3,000	$4,122,990

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$614,000	—	$1,210,806	$3,558,849	$361,339	$3,000	$5,747,994
Marc J. Wilson	CFO	$450,495	—	$475,288	$1,395,955	$188,757	$3,000	$2,513,495
Stephen F. Betz	Chief Scientific Officer	$471,927	—	$463,504	$1,360,700	$197,737	$3,000	$2,496,868
Jeff Knight	COO	$459,167	—	$579,380	$1,125,670	$195,145	$3,000	$2,362,362
Dana Pizzuti	Chief Medical and Development Officer	$529,167	—	$88,380	$259,770	$221,721	$3,000	$1,102,038

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$567,000	—	—	$3,236,940	$337,109	$3,000	$4,144,049
Jeff Knight	COO	$136,111	$40,000	—	$2,742,400	$58,527	$3,000	$2,980,038
Ajay Madan	Chief Development Officer	$430,833	—	—	$1,442,310	$180,950	$3,000	$2,057,093

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$543,550	—	—	$3,006,000	$276,782	—	$3,826,332
Ajay Madan	Chief Development Officer	$412,967	—	—	$1,052,100	$154,560	—	$1,619,627
Marc. S. Wilson	CFO	$384,200	—	—	$1,052,100	$143,520	—	$1,579,820

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	CEO	$541,708	—	—	$3,051,275	$173,679	—	$3,766,662
Alan Krasner	Chief Endocrinologist	$421,708	—	—	$973,811	$98,952	$51,310	$1,545,781
Marc. S. Wilson	CFO	$364,749	—	—	$973,811	$85,248	—	$1,423,808

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
R. Scott Struthers	President, Chief Executive Officer and Director	$409,913	$110,800	—	$2,257,637	$259,875	$3,210	$3,041,435
Alan Krasner	Chief Endocrinologist	$188,920	—	—	$1,243,951	$75,514	$63,575	$1,571,960
Marc. S. Wilson	—	$272,466	$25,000	—	$612,229	$120,278	$1,000	$1,030,973

Key facts CIK 1658247 CUSIP 22663K107 13F (30d) 24 filings 23 filers Visit website Investor relations